What is the main business of Immunotronics?

The main business activity of Immunotronics focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 7, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Frezerów 2, 20-213 Lublin.

What is the share capital?

The share capital of the company is PLN 900 (approx. $243).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of USD 0, representing a decrease of 100.0% compared to 2024.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of USD 4,979. For comparison, in 2024 the loss was USD 3,062, meaning the company increased its loss by 62.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to USD 165 in 2025, representing 3% of all operating expenses.

ImmunotronicsP.S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-06-07

Activity description

Immunotronics is revolutionizing sepsis diagnostics by providing fast, accurate, and affordable tests using immunoFET technology and a multi-biomarker approach. Their diagnostic process allows for rapid analysis of blood samples, delivering test results in under one minute without the need for specialized equipment or trained personnel. The company utilizes machine learning to enhance diagnostic accuracy and improve patient outcomes.

Registered address

ul. Frezerów 2, 20-213 Lublin, Poland

Website

immunotronics.net

Phone

Social media

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 0.16MedianUSD 38.31kAverageUSD 2.31m

Net profit

This companyUSD -4.98kMedianUSD -1.50kAverageUSD -84.98k

Operating costs

This companyUSD 4.82kMedianUSD 56.25kAverageUSD 2.29m

Assets

This companyUSD 1.96kMedianUSD 116.77kAverageUSD 2.72m

Industry

Bank accounts

Registered as a VAT taxpayer on 2024-10-01. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

5 public aid cases recorded, with a total value of $51,633.

Grant date	Purpose	Gross amount	Granting body
Jun 1, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	——	OIC Poland Fundacja Akademii Wsei
May 25, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	——	Katowicka Specjalna Strefa Ekonomiczna S.A.
Sep 5, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	——	Fundacja Koalicji na Rzecz Polskich Innowacji

Tenders

No recorded participation in tenders.

Authorized Representatives

Marcin Szymon Filipiak — Dyrektor

Manner of representation

Each director is authorized to submit declarations of will on behalf of the company independently.

Beneficial owners

Person	Rights
Marcin Szymon Filipiak (36)	Shareholder of a simple joint-stock company, 57.0%

Competitors

	Name	Revenue	Website
	Meritrosp. z o.o.	$0.05	meritro.com

Change history

Date	Event
2026-08-26	Address change (Gospodarcza 26, 20-213, Lublin → Ul. Frezerów 2, 20-213, Lublin)
2026-08-26	PKD change (Added: 74.30.Z)
2024-06-07	Entered in the register

FAQ

Last updated: 2026-08-26